Avenue therapeutics reports q1 loss per share of $0.08

Avenue therapeutics reports first quarter 2020 financial results and recent corporate highlights.q1 loss per share $0.08.qtrly loss per share $0.08.
ATXI Ratings Summary
ATXI Quant Ranking